About Statens Serum Institut
Statens Serum Institut is a company based in Copenhagen (Denmark) founded in 1902, and was acquired by J Pharma Holding in March 2017. Provider of scuba diving services and PADI instruction. The company has 922 employees. Its chief executive, as recorded, is Niels Strandberg Pedersen. Its website ssi.dk draws about 154 thousand monthly visits. Statens Serum Institut offers products and services including Vaccinations and Diagnostics.
Company details
Founded in 1902 and based in Copenhagen, Denmark, Statens Serum Institut operates in the scuba diving sector. Dives are conducted at wreck and reef sites, with instruction provided through PADI, DSAT, and IDCIESSI programs, including extended range courses. Equipment rental and boat trips to dive locations are available. Services cater to beginners and experienced divers alike, under the leadership of CEO Niels Strandberg Pedersen.
- Headquarters Copenhagen, Denmark
- Employees 922
- Stage Acquired
- Website category Health
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ssi.dk
- Social LinkedIn X
- Acquired by J Pharma Holding (Mar 2017)
- Legal Name Statens Serum Institut
- Latest Funding Round$263.15K (USD), Grant
Jan 2017
- InvestorsEuropean Union
& 3 more
- Employee Count922
- Acquired by
Products & Services of Statens Serum Institut
Statens Serum Institut offers a comprehensive portfolio of products and services, including Vaccinations and Diagnostics.
Vaccinations are provided for various infectious diseases as part of public health initiatives
Diagnostic services are offered for infections and related health conditions
Funding Insights of Statens Serum Institut
- Total Rounds 5
- Last Round Grant β $263,148
- Investors Count 2
All 5 funding rounds of Statens Serum Institut with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $263,148 | Grant | β | β | |
| May 2015 | $656,376 | Grant | β | β | |
| Jan 2014 | Grant | β | β | ||
| May 2012 | $588,531 | Grant | β | β | |
| Mar 2010 | Grant | β | β |
4 investors in total: 4 institutional.
Investors in Statens Serum Institut
Statens Serum Institut has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, AJ Pharma Holding and Adelis Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Adelis Equity is engaged in growing Nordic businesses through partnerships. | adelisequity.com | Stockholm, Sweden | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| hhs.gov | ||||
AJ Pharma Holding is focused on healthcare investment and technology. | 2012 | ajpharmaholding.com | Kuala Lumpur, Malaysia |
Investor details for Statens Serum Institut
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Statens Serum Institut
13 people are tracked at Statens Serum Institut (6 in leadership, 7 in team); the tracked headcount is 922.
| Name | Role | Group |
|---|---|---|
Niels Strandberg Pedersen | CEO | Leadership |
Doug Sproule | COO Sustainable Solutions International | Leadership |
Gitte Stawski | Quality Control Director | Leadership |
Heather Boyd | Senior Researcher (epidemiologist) And Head Of Section | Leadership |
Gabriel Pedersen | Head Of Section, Adjuvant Research | Leadership |
Michael Christiansen | Research Director, Dept For Congenital Disorders | Leadership |
Bent Hygum | Funktionschef QA | Team |
Jesper Larsen | Senior Scientist | Team |
Ian Skovsted | Research Scientist | Team |
Morten Rasmussen | Unit Leader | Team |
Peter Nyborg Rasmussen | Afdelingschef | Team |
Rafah G. Nagras | Delegated Qp, Batch Release | Team |
Lasse S. Vestergaard | Senior Medical Officer (overlæge), Team Lead, Division Of Infectious Diseases Preparedness | Team |
Complete people profiles for Statens Serum Institut
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Statens Serum Institut
5 dated milestones of Statens Serum Institut across 115 years, from founding to its latest funding, stage changes and deals.
- Founded Statens Serum Institut is founded.
- Funding First funding round.
- Exit Acquired by Adelis Equity Partners.
- Funding Latest funding round, Grant, of $263K.
- Exit Acquired by J Pharma Holding.
Web traffic of Statens Serum Institut
The website of Statens Serum Institut (ssi.dk) receives about 154.1K visits a month and ranks #231,398 among all websites worldwide, #7,671 in Health.
- Monthly visits154.1K
▼ 15.6% vs previous month
- Unique visitors95.5K
per month
- Global rank#231,398
among all websites
- Category rank#7,671
Health · Health
- Bounce rate49%
- Pages per visit2.3
- Average visit1 min 53 sec
- DevicesDesktop 26% Β· Mobile 74%
Websites whose visitors overlap most with Statens Serum Institut. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sundhed.dk | 100% | 2.4M | #23,667 | View details | |
| sst.dk | 67% | 344.7K | #128,945 | View details | |
| sikkerrejse.dk | 66% | 107.2K | #286,164 | View details | |
| rigshospitalet.dk | 64% | #257,155 | View details | ||
sundhedsstyrelsen.dk | sundhedsstyrelsen.dk | 57% | #8,688,646 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Statens Serum Institut
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Statens Serum Institut
Complete news archive for Statens Serum Institut
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Statens Serum Institut
Statens Serum Institut was founded in 1902 and raised its 1st funding round 108 years after it was founded.
Statens Serum Institut is headquartered in Copenhagen, Denmark.
Niels Strandberg Pedersen is the CEO of Statens Serum Institut, as recorded in our data.
Statens Serum Institut has 922 employees.
Founded in 1902 and based in Copenhagen, Denmark, Statens Serum Institut operates in the scuba diving sector. Dives are conducted at wreck and reef sites, with instruction provided through PADI, DSAT, and IDCIESSI programs, including extended range courses. Equipment rental and boat trips to dive locations are available. Services cater to beginners and experienced divers alike, under the leadership of CEO Niels Strandberg Pedersen.
Statens Serum Institut offers Vaccinations and Diagnostics.
Statens Serum Institut has 4 investors. Key investors include European Union, AJ Pharma Holding, Adelis Equity, and HHS.
Statens Serum Institut operates through Statens Serum Institut.
Yes. Statens Serum Institut was acquired by J Pharma Holding in March 2017.
The website of Statens Serum Institut receives about 154 thousand visits a month and ranks #231,398 among all websites worldwide.

